原发性开角型青光眼与1型和2型糖尿病患者糖尿病视网膜病变风险的关联:一项大型全球数据库研究
该回顾性队列研究利用TriNetX全球数据库,纳入2005年1月1日至2023年1月1日期间44,359例合并原发性开角型青光眼(POAG)的糖尿病患者和4,393,300例无青光眼的糖尿病患者,经倾向评分匹配后各39,680例。结果显示,10年时合并POAG的1型糖尿病患者发生任何糖尿病视网膜病变(DR)的风险比(RR)为4.12,增殖性DR(PDR)的RR为7.02;2型糖尿病患者的相应RR分别为2.47和3.82。合并POAG者10年DR累积发生率为5.45%,无青光眼者为2.12%(校正风险比aHR为2.33)。结论强调POAG与DR发生存在显著关联,建议对合并青光眼的糖尿病患者进行警惕性筛查和综合管理。
要点
- 合并POAG的1型糖尿病患者10年任何DR风险RR为4.12,PDR风险RR为7.02。
- 合并POAG的2型糖尿病患者10年任何DR风险RR为2.47,PDR风险RR为3.82。
- 合并POAG者10年DR累积发生率为5.45%,无青光眼者为2.12%(aHR 2.33)。
核心结论
- 研究结果强调POAG与1型和2型糖尿病患者DR发生存在显著关联,需要对合并青光眼的糖尿病患者进行警惕性筛查和综合管理以降低DR风险。
- 未来研究应深入阐明驱动这些观察到的关联的因果机制。
研究设计与样本
- 回顾性队列研究,利用TriNetX Research Network全球患者数据库。
- 纳入44,359例合并POAG的糖尿病患者和4,393,300例无任何青光眼的糖尿病患者,年龄≥18岁。
- 倾向评分匹配将队列调和至每组39,680例,覆盖2005年1月1日至2023年1月1日的诊断。
- 使用特定ICD-10代码分析糖尿病和青光眼数据,匹配时调整年龄、性别、种族/民族、血液标志物、相关病史和眼科服务使用。
- 主要结局为从个体索引日期起1年、5年和10年时首次发生DR,包括非增殖性DR(NPDR)和增殖性DR(PDR)。
主要发现
- 10年时,合并POAG的1型糖尿病患者发生任何DR的风险比(RR)为4.12(95%CI 3.05-5.57,P<0.0001),发生PDR的RR为7.02(95%CI 3.62-13.61,P<0.0001)。
- 10年时,合并POAG的2型糖尿病患者发生任何DR的RR为2.47(95%CI 2.28-2.68,P<0.0001),发生PDR的RR为3.82(95%CI 3.09-4.70,P<0.0001)。
- 10年时,1型和2型糖尿病患者中POAG对DR风险的合并关联在POAG患者中显著更高(5.45% vs 无青光眼者2.12%),校正风险比(aHR)为2.33(95%CI 2.14-2.53)。
- 十年后,POAG组DR累积发生率显著高于无青光眼对照组(log-rank P<0.001)。
临床怎么用
- 作者强调需要对合并青光眼的糖尿病患者进行警惕性筛查和综合管理,以降低DR风险。
- 原文未据此给出其他具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the correlation between primary open-angle glaucoma (POAG) and the risk of developing diabetic retinopathy (DR) in patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). DESIGN: A retrospective cohort study leveraging the global patient database of TriNetX Research Network. PARTICIPANTS: The study included 44 359 patients with diabetes mellitus (DM) with POAG and 4 393 300 patients with DM without any glaucoma ≥ 18 years of age. Propensity score matching harmonized the cohorts to 39 680 patients each, covering diagnoses from January 1, 2005, to January 1, 2023. METHODS: We analyzed data using specific International Classification of Diseases, 10th Revision (ICD-10) codes for DM and glaucoma. We matched the cohorts using propensity score matching, adjusting for age, sex, race/ethnicity, blood markers, relevant medical history, and ophthalmic service use. MAIN OUTCOME MEASURES: The primary outcome was the first-time occurrence of DR, including nonproliferative DR (NPDR) and proliferative DR (PDR), in patients with DM with and without glaucoma at 1-, 5-, and 10-year intervals from their individual index dates. RESULTS: At 10 years, patients with T1DM with POAG exhibited a heightened risk for any DR (adjusted risk ratios [RRs], 4.12; 95% confidence interval [CI], 3.05-5.57, P < 0.0001) and PDR (RR, 7.02; 95% CI, 3.62-13.61, P < 0.0001). Patients with T2DM and POAG also faced an increased 10-year risk for any DR (RR, 2.47; 95% CI, 2.28-2.68, P < 0.0001) and PDR (RR, 3.82; 95% CI, 3.09-4.70, P < 0.0001). The combined association of POAG on DR risk in those with T1DM and T2DM at 10 years was found to be significantly higher among patients with POAG (5.45%) compared with those without glaucoma (2.12%) (adjusted hazard ratio [aHR], 2.33; 95% CI, 2.14-2.53). The cumulative incidence of DR was significantly higher in the POAG group compared with nonglaucoma counterparts after a decade (log-rank P < 0.001). CONCLUSIONS: Our findings underscore a substantial association between POAG and DR development in both T1DM and T2DM patients, emphasizing the need for vigilant screening and comprehensive management in glaucomatous patients with DM to mitigate the risk of DR. Future research should delve into elucidating the causal mechanisms driving these observed associations. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
引用
- Chauhan MZ, Elhusseiny AM, Kishor KS, et al. Association of Primary Open-Angle Glaucoma with Diabetic Retinopathy among Patients with Type 1 and Type 2 Diabetes: A Large Global Database Study. Ophthalmology. 2024. PMID: 38215989. doi:10.1016/j.ophtha.2024.01.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。